Rossari Biotech Limited — Board Meeting, 27-04-2026: Outcome of Board Meeting

Rossari Biotech's board approved Q4 consolidated PAT of Rs 45.97 Cr and FY26 PAT of Rs 149.21 Cr. A Re 0.50/share dividend was declared, a new Independent Director appointed, and a new R&D facility in Navi Mumbai announced. Capacity expansion is rescheduled.